About this trial
A Single-center, open, prospective study,for analyzing the local recurrence rate, the incidence of incision complications and the aesthetic effect of intraoperative radiotherapy in early breast cancer patients after breast-conserving surgery.
Eligibility criteria
Qualifiers
Age ≥55 years old;
Cytology or histology confirmed invasive breast cancer or intraductal carcinoma in situ (DCIS) with a clinical stage of Tis-1N0M0;
Patients who are willing to preserve milk and intend to undergo breast-conserving surgery;
If invasive breast cancer is confirmed, the surgical margin negative ≥2mm should be met. If DCIS is confirmed, the surgical margin should be negative ≥3mm;
Disqualifiers
Simultaneous diagnosis of bilateral or multifocal breast cancer;
Previous ipsilateral breast cancer and/or prior chest wall radiation therapy;
There are active connective tissue diseases such as scleroderma and systemic lupus erythematosus in the chest;
The investigators did not consider the patient suitable for participation in any other conditions of the study.
Trial design
Treatments tested in this trial
- radiotherapy